Eriko Aizu-Yokota
Overview
Explore the profile of Eriko Aizu-Yokota including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oka M, Toyoda C, Kaneko Y, Nakazawa Y, Aizu-Yokota E, Takehana M
Mol Vis
. 2010 Jun;
16:945-53.
PMID: 20577594
Purpose: Side population (SP) cells were isolated and the possibility whether lens epithelial cells contain stem cells was investigated. Methods: Mouse lens epithelial cells were stained by Hoechst 33342 and...
2.
Tanifuji S, Aizu-Yokota E, Funakoshi-Tago M, Sonoda Y, Inoue H, Kasahara T
Int Immunopharmacol
. 2010 Apr;
10(7):769-76.
PMID: 20399908
Mast cells play a key role in allergic inflammation by releasing various mediators, such as histamine, serotonin, leukotrienes and cytokines. A signaling cascade of events activated by stimulation with antigens...
3.
Abe M, Funakoshi-Tago M, Tago K, Kamishimoto J, Aizu-Yokota E, Sonoda Y, et al.
Int Immunopharmacol
. 2009 Mar;
9(7-8):870-7.
PMID: 19327411
The somatic Jak2 mutation (V617F) was identified in most patients with polycythemia vera (PV). Here, we show that the activating Jak2 V617F mutant completely protected Ba/F3 cells from cytokine withdrawal-induced...
4.
Funakoshi-Tago M, Tago K, Sumi K, Abe M, Aizu-Yokota E, Oshio T, et al.
J Biol Chem
. 2009 Mar;
284(19):12680-90.
PMID: 19289461
JAK2 plays important roles in the regulation of a variety of cellular processes including cell migration, proliferation, and protection from apoptosis. Recently the L611S point mutation in JAK2 has been...
5.
Oshio T, Sasaki Y, Funakoshi-Tago M, Aizu-Yokota E, Sonoda Y, Matsuoka H, et al.
Int Immunopharmacol
. 2009 Jan;
9(4):403-11.
PMID: 19162238
Atopic dermatitis (AD) is a chronic inflammatory skin disease, which is accompanied by marked increases in the levels of inflammatory cells, including mast cells and eosinophils as well as T...
6.
Yoshida N, Aizu-Yokota E, Sonoda Y, Moriwaki Y, Kishi K, Kasahara T
Biol Pharm Bull
. 2007 Oct;
30(10):1826-32.
PMID: 17917245
When a human leukemic cell line, HT93 was incubated with all-trans retinoic acid (ATRA), IL-5, or both, this cell line was differentiated into eosinophic lineage, in that an eosinophilic specific...
7.
Murakami Y, Aizu-Yokota E, Sonoda Y, Ohta S, Kasahara T
J Biochem
. 2007 Feb;
141(3):401-10.
PMID: 17301078
Continuous endoplasmic reticulum (ER) stress, such as the accumulation of unfolded proteins, results in cell death and relates to the pathogenesis of some neurodegenerative diseases. Treatment of brefeldin A, an...
8.
Ichikawa D, Funakoshi-Tago M, Aizu-Yokota E, Sonoda Y, Inoue J, Kasahara T
Biochem Biophys Res Commun
. 2006 Oct;
351(1):93-8.
PMID: 17055451
Tumor necrosis factor receptor (TNFR)-associated factor 6 (TRAF6) has mainly been involved in signaling from CD40 and IL-1 receptor family. While TNF-alpha exerts various biological effects including cell death, the...
9.
Rokudai A, Terui Y, Kuniyoshi R, Mishima Y, Mishima Y, Aizu-Yokota E, et al.
Biol Pharm Bull
. 2006 Jun;
29(6):1102-9.
PMID: 16755001
Allergic asthma and allergic dermatitis are chronic inflammatory diseases and are characterized by an accumulation of eosinophils at sites of inflammation. Eotaxin-1/CCL11 and eotaxin-3/CCL26 are members of the CC chemokine...
10.
Matsui S, Sonoda Y, Sekiya T, Aizu-Yokota E, Kasahara T
Int Immunopharmacol
. 2006 Jan;
6(3):369-75.
PMID: 16428072
We recently demonstrated that glycyrrhizin (GL) and its derivatives down-regulate TNFalpha- and IL-4-induced eotaxin 1 production by the human fetal lung fibroblast line HFL-1 at protein or mRNA levels. In...